Safety assessment involves a comprehensive evaluation of all ingredients in the vaccine candidate, including the active antigen and any additives. The assessment considers both acute and chronic exposure scenarios. Safety profiles are built from data collected in preclinical and clinical trials, and these profiles are reviewed by regulatory agencies before approval.
